Perigon Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Buy
19,740
+1,033
+6% +$92.1K 0.03% 410
2025
Q4
$1.48M Buy
18,707
+813
+5% +$63.7K 0.03% 442
2025
Q3
$1.43M Buy
17,894
+1,926
+12% +$164K 0.03% 423
2025
Q2
$1.45M Sell
15,968
-4,524
-22% -$413K 0.03% 397
2025
Q1
$1.92M Sell
20,492
-13,185
-39% -$1.18M 0.05% 309
2024
Q4
$2.98M Buy
33,677
+1,184
+4% +$113K 0.07% 245
2024
Q3
$3.37M Buy
32,493
+812
+3% +$82.8K 0.09% 210
2024
Q2
$3.07M Sell
31,681
-662
-2% -$61.1K 0.09% 197
2024
Q1
$2.91M Sell
32,343
-6,489
-17% -$550K 0.09% 203
2023
Q4
$3.1M Buy
38,832
+3,900
+11% +$293K 0.1% 175
2023
Q3
$2.48M Sell
34,932
-186
-0.5% -$13.9K 0.1% 183
2023
Q2
$2.71M Buy
35,118
+14,515
+70% +$1.12M 0.11% 177
2023
Q1
$1.55M Buy
20,603
+893
+5% +$66.4K 0.09% 205
2022
Q4
$1.55M Buy
19,710
+5,182
+36% +$389K 0.1% 198
2022
Q3
$1.02M Buy
14,528
+3,630
+33% +$285K 0.09% 201
2022
Q2
$873K Buy
10,898
+140
+1% +$10.9K 0.07% 227
2022
Q1
$816K Buy
10,758
+169
+2% +$13.4K 0.06% 267
2021
Q4
$904K Buy
10,589
+778
+8% +$60.8K 0.06% 236
2021
Q3
$742K Sell
9,811
-478
-5% -$38K 0.06% 237
2021
Q2
$837K Buy
10,289
+1
+0% +$82 0.07% 224
2021
Q1
$811K Sell
10,288
-77
-0.7% -$6.04K 0.08% 206
2020
Q4
$886K Buy
10,365
+264
+3% +$21.8K 0.1% 159
2020
Q3
$779K Buy
10,101
+656
+7% +$50K 0.11% 152
2020
Q2
$692K Sell
9,445
-29
-0.3% -$2.06K 0.11% 149
2020
Q1
$662K Buy
9,474
+1,291
+16% +$91K 0.12% 137
2019
Q4
$560K Buy
8,183
+794
+11% +$54.1K 0.11% 132
2019
Q3
$505K Sell
7,389
-185
-2% -$13.4K 0.12% 119
2019
Q2
$543K Sell
7,574
-2,435
-24% -$173K 0.13% 120
2019
Q1
$692K Hold
10,009
0.16% 99
2018
Q4
$623K Sell
10,009
-1,838
-16% -$115K 0.16% 106
2018
Q3
$793K Sell
11,847
-2,219
-16% -$148K 0.2% 87
2018
Q2
$912K Buy
14,066
+5,680
+68% +$372K 0.27% 82
2018
Q1
$601K Buy
8,386
+15
+0.2% +$1.08K 0.22% 77
2017
Q4
$632K Sell
8,371
-5,646
-40% -$412K 0.24% 69
2017
Q3
$1.02M Sell
14,017
-22,551
-62% -$1.63M 0.33% 67
2017
Q2
$2.71M Sell
36,568
-23
-0.1% -$1.71K 0.59% 48
2017
Q1
$2.68M Buy
36,591
+113
+0.3% +$7.91K 0.57% 50
2016
Q4
$2.68M Buy
36,478
+2,990
+9% +$205K 0.59% 50
2016
Q3
$2.48M Buy
33,488
+270
+0.8% +$20K 0.64% 48
2016
Q2
$2.43M Buy
33,218
+2,462
+8% +$175K 0.65% 44
2016
Q1
$2.26M Hold
30,756
0.71% 41
2015
Q4
$2.05M Buy
30,756
+17,653
+135% +$1.17M 0.57% 49
2015
Q3
$832K Buy
13,103
+268
+2% +$17.5K 0.25% 103
2015
Q2
$840K Hold
12,835
0.22% 106
2015
Q1
$890K Buy
12,835
+5,715
+80% +$395K 0.24% 98
2014
Q4
$493K Buy
7,120
+65
+0.9% +$4.39K 0.15% 131
2014
Q3
$460K Sell
7,055
-4,381
-38% -$289K 0.14% 126
2014
Q2
$780K Buy
11,436
+180
+2% +$12.1K 0.22% 97
2014
Q1
$730K Hold
11,256
0.4% 55
2013
Q4
$734K Buy
+11,256
New +$720K 0.41% 49

Other funds holding CL

Perigon Wealth Management's CL Position: Q1 2026 in Review

Perigon Wealth Management increased its Colgate-Palmolive (CL) stake by 5.5% in Q1 2026, buying an estimated $92.1K and bringing the position to 19,740 shares worth $1.68M. The position accounts for 0.03% of the portfolio, ranked #410.

Perigon Wealth Management first reported a position in CL in Q4 2013 and has held it in 50 quarters since. The position peaked at $3.37M in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Perigon Wealth Management held 19,740 shares of Colgate-Palmolive worth $1.68M as of Q1 2026.
  • Perigon Wealth Management bought 1,033 Colgate-Palmolive shares in Q1 2026, an estimated $92.1K.
  • Colgate-Palmolive made up 0.03% of Perigon Wealth Management's portfolio in Q1 2026, its #410 holding.
  • Perigon Wealth Management first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 50 quarters since.
  • Perigon Wealth Management's Colgate-Palmolive position peaked at $3.37M in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.